Actively Recruiting

Age: 18Years +
All Genders
NCT07290634

Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion

Led by Zeliha Alicikus · Updated on 2026-04-14

4

Participants Needed

2

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to compare the incidence of thromboembolic complications among trauma patients receiving PCC, rFVIIa, both agents, or neither during massive transfusion. Secondary objectives include comparing mortality, transfusion requirements, intensive care unit (ICU) and hospital length of stay, ventilator-free days, and the incidence of transfusion-associated adverse events such as transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). Subgroup analyses will evaluate outcomes in patients with and without laboratory-confirmed TIC (INR \>1.2).

CONDITIONS

Official Title

Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 65 18 years
  • Trauma patients admitted directly from the scene with highest-level trauma activation
  • Injury Severity Score (ISS) > 15
  • Requirement for massive transfusion defined as 65 3 units packed red blood cells within the first hour or 65 10 units within the first 24 hours
Not Eligible

You will not qualify if you...

  • Traumatic cardiac injury
  • Death anticipated within the first hour of admission: ISS score > 49
  • Pre-injury anticoagulant therapy
  • Known pregnancy
  • Pre-injury terminal illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

UF Health Jacksonville (Shands Hospital)

Jacksonville, Florida, United States, 32209

Actively Recruiting

2

UF Health Jacksonville (Shands Hospital)

Jacksonville, Florida, United States, 32218

Actively Recruiting

Loading map...

Research Team

A

Ayten SARAÇOĞLU, Prof,MD

CONTACT

T

Tolga SARAÇOĞLU, Prof,MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here